Thomas Bordner

Thomas Bordner

Prince Lobel Tye LLP

Partner

Tom leverages his biotechnology industry experience gained from an extensive in-house career and private practice, to solve complex intellectual property issues and provide strategic advice to clients in all aspects of patent and other forms of intellectual property (trade secret, trademark and copyright) acquisition, protection, portfolio evaluation and management, licensing and asset monetization. He further provides clients with legal opinions related to validity and enforceability, patentability, freedom to operate, portfolio evaluations, and pre-transaction due diligence investigations. Tom’s experience additionally includes developing and executing worldwide patent procurement strategies designed to protect business critical inventions. He has considerable experience guiding IP intensive transactions and for entrepreneurs and venture capital groups in devising strategies to protect their investments to build value in their intellectual property portfolios.

Having been both a provider and consumer of intellectual property related legal services, Tom provides clients with chief patent counsel level services and guidance in a cost-effective way. Tom’s clients include key decision makers in a variety of public and private organizations, including, small, and mid-sized biotech and medical device companies and research universities both in the U.S. and abroad.

Prior to Prince Lobel, Tom was the Founder of BIPLaw LLC where he counseled emerging, small, and mid-sized biotech companies and research universities in the fields of molecular medicine, prophylactic and therapeutic vaccines, therapeutic proteins and antibodies including production and delivery techniques, cancer related therapies and drugs, bioinformatics, medical diagnostics, and medical devices.